Latest Personal Genome Diagnostics Inc. Stories
Study in Science Translational Medicine Confirms that Many Genetic Alterations Identified by Tumor-Only Sequencing are 'False Positives' BALTIMORE, April 15, 2015 /PRNewswire/ --
PGDx's CancerSelectTM Targeted Gene Profiling Panel Will Be Run for All Newly-Diagnosed Lung Cancer Patients in New England Veteran's Integrated Service Network (VISN 1) Precision Oncology Program
HLI Licenses PGDx's Suite of Cancer Solutions to Expand the Company's Cancer Genomics Offering BALTIMORE and LA JOLLA, Calif., Jan.
--PlasmaSelect-R(TM) Accurately Identifies Tumor-Specific Sequence Mutations and Translocations in 63 Cancer Genes from Blood Samples-- BALTIMORE, Jan.
Recent Senior Level Hires Bring Additional Experience in Operations and R&D Management BALTIMORE, Dec. 30, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc.
--Genomic Data in Study Published in Nature Communications Suggests New Treatment Strategies for These Hard to Treat Women's Reproductive Cancers-- BALTIMORE and CAMBRIDGE, Mass., Sept.
--Study in Nature Genetics Used PGDx Exome Analysis to Identify Previously Unknown Mutation with Potential as New Drug Target for Lethal Childhood Brain Cancer-- BALTIMORE, June
--First-in-Class CLIA Assay for Detection of Tumor-Specific Gene Amplifications Using Circulating Cell-Free DNA-- BALTIMORE, April 2, 2014 /PRNewswire/ -- Personal Genome Diagnostics
--New Publication in Science Translational Medicine Confirms Utility of Cell-Free Circulating Tumor DNA (ctDNA) for Cancer Drug Development and Diagnosis-- BALTIMORE, Md., Feb.